Bill Text: NY A04233 | 2017-2018 | General Assembly | Introduced


Bill Title: Extends the preferred drug program to medicaid managed care providers and offers the program to other health plans.

Spectrum: Strong Partisan Bill (Democrat 28-2)

Status: (Introduced - Dead) 2018-01-03 - referred to ways and means [A04233 Detail]

Download: New_York-2017-A04233-Introduced.html


                STATE OF NEW YORK
        ________________________________________________________________________
                                          4233
                               2017-2018 Regular Sessions
                   IN ASSEMBLY
                                    February 1, 2017
                                       ___________
        Introduced by M. of A. GOTTFRIED, THIELE, RODRIGUEZ, MOSLEY, MAGNARELLI,
          LUPARDO,  CRESPO,  BLAKE, GALEF, JAFFEE, SEAWRIGHT, MONTESANO, TITONE,
          GUNTHER, LIFTON, SEPULVEDA, HOOPER, DINOWITZ, OTIS,  JENNE,  ABINANTI,
          HYNDMAN,  ORTIZ  --  Multi-Sponsored  by  --  M.  of A. CARROLL, COOK,
          CROUCH, ENGLEBRIGHT, GLICK, SIMON -- read once  and  referred  to  the
          Committee on Health
        AN  ACT  to  amend the social services law and the public health law, in
          relation to extending the preferred drug program to  medicaid  managed
          care  providers and offering the program to other health plans; and to
          repeal certain provisions of the social services law relating thereto
          The People of the State of New York, represented in Senate and  Assem-
        bly, do enact as follows:
     1    Section 1. Legislative findings. This legislature finds that the costs
     2  of  many prescription drugs in the market have been escalating unreason-
     3  ably. The preferred drug program and the clinical  drug  review  program
     4  under  the  public  health law provide effective mechanisms for assuring
     5  access to quality, effective and safe drugs to  patients  at  reasonable
     6  cost.  Providing  prescription  drugs  to  Medicaid  managed health care
     7  provider participants through these programs will maximize the  Medicaid
     8  program's  ability  to  negotiate  more  substantial  rebates  with drug
     9  manufacturers (effectively, lower  prices),  while  protecting  Medicaid
    10  managed  care  provider participants. Offering non-Medicaid health plans
    11  the opportunity to use these programs will help lower  costs  for  those
    12  health plans and those who pay their premiums, while protecting individ-
    13  uals  covered by those plans, and will also further increase the negoti-
    14  ating power of the programs.
    15    § 2. The social services law is amended by adding a new section  365-i
    16  to read as follows:
    17    §  365-i.  Prescription  drugs  in medicaid managed care programs.  1.
    18  Definitions. (a) The definitions of terms in section two hundred seventy
    19  of the public health law shall apply to this section.
    20    (b) As used in this  section,  unless  the  context  clearly  requires
    21  otherwise:
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD09321-01-7

        A. 4233                             2
     1    (i)  "Managed  care  provider"  means  a  managed  care provider under
     2  section three hundred sixty-four-j of this article, a managed long  term
     3  care  plan under section forty-four hundred three-f of the public health
     4  law, or any other entity that provides or arranges for the provision  of
     5  medical  assistance  services  and  supplies to participants directly or
     6  indirectly (including by referral), including case management, including
     7  the managed care provider's authorized agents.
     8    (ii) "Participant" means a medical assistance recipient who  receives,
     9  is  required  to receive or elects to receive his or her medical assist-
    10  ance services from a managed care provider.
    11    2. Providing and payment for prescription drugs for  medicaid  managed
    12  care  provider  participants. Prescription drugs eligible for reimburse-
    13  ment under this article prescribed in relation to a service provided  by
    14  a  managed  care  provider  shall  be  provided  and  paid for under the
    15  preferred drug program and the clinical drug review program under  title
    16  one of article two-A of the public health law. The managed care provider
    17  shall  account  to  and reimburse the department for the net cost to the
    18  department for prescription drugs provided to the managed  care  provid-
    19  er's  participants.  Payment for prescription drugs shall be included in
    20  the capitation payments to the managed care  provider  for  services  or
    21  supplies provided to a managed care provider's participants.
    22    §  3.  Section 270 of the public health law is amended by adding a new
    23  subdivision 15 to read as follows:
    24    15. "Third-party health care payer"  has  its  ordinary  meanings  and
    25  includes  an  entity  such  as a fiscal administrator, or administrative
    26  services provider that participates in the administration  of  a  third-
    27  party health care payer system.
    28    § 4. The public health law is amended by adding a new section 274-a to
    29  read as follows:
    30    §  274-a.  Use  of  preferred  drug  program  and clinical drug review
    31  program. The commissioner shall contract  with  any  third-party  health
    32  care  payer  that  so chooses, to use the preferred drug program and the
    33  clinical drug review program to provide and pay for  prescription  drugs
    34  for  the  third-party  health  care payer's enrollees. To contract under
    35  this section, the third-party health care payer shall  provide  coverage
    36  for  prescription  drugs  authorized  under  this title. The third-party
    37  health care payer shall account to and reimburse the department for  the
    38  net cost to the department for prescription drugs provided to the third-
    39  party  health  care  payer's enrollees. The contract shall include terms
    40  required by the commissioner.
    41    § 5. Section 272 of the public health law is amended by adding  a  new
    42  subdivision 12 to read as follows:
    43    12.  No prior authorization shall be required under the preferred drug
    44  program for: (a) atypical  anti-psychotics;  (b)  anti-depressants;  (c)
    45  anti-retrovirals  used  in the treatment of HIV/AIDS; (d) anti-rejection
    46  drugs used in  the  treatment  of  organ  and  tissue  transplants;  (e)
    47  seizure,  epilepsy,  endocrine,  hematologic and immunologic therapeutic
    48  classes; and (f) any other therapeutic class for the treatment of mental
    49  illness or HIV/AIDS, recommended by the committee and  approved  by  the
    50  commissioner under this title.
    51    §  6. Subdivisions 25 and 25-a of section 364-j of the social services
    52  law are REPEALED.
    53    § 7. This act shall take effect on the one hundred eightieth day after
    54  it shall have become a law; provided, however, that the commissioner  of
    55  health  is immediately authorized and directed to take actions necessary
    56  to implement this act when it takes effect.
feedback